Back grey arrow rt.gif
 
 
Bristol-Myers Squibb Supports HarborPath to Help Uninsured Individuals Living with HIV/AIDS Access Prescription Medicines
 
 
  Dear Colleagues:
 
As you know, NASTAD has been working closely with HarborPath< http://www.harborpath.org/> to develop a single place for uninsured individuals living with HIV who otherwise qualify for manufacturer-sponsored patient assistance programs (PAPs) to apply for and receive their HIV medications. HarborPath's "one stop shop" portal< https://www.harborpath.org/userdata/harborpath/DeAnneAdmin-1348254266/assets/Harborpath_Fact_Sheet_VER_2_15_2013.pdf> provides a streamlined, online process to qualify individuals and deliver the donated medications through a mail-order pharmacy. HarborPath recently announced that BMS will begin offering its medications through HarborPath in the continuing pilot phase of this program (see attached press release). BMS joins Gilead Sciences, Merck and ViiV Healthcare who are already participating in HarborPath's online portal. HarborPath also continues to seek participation in this program from other companies. Future plans for HarborPath include expansion to clinics across the country.
 
In addition to the above collaboration, HarborPath began administering the ADAP waiting list program in June 2013. The HarborPath ADAP waiting list access program < http://www.harborpath.org/wait-list> includes all HIV medications manufactured by AbbVie, BMS, Gilead Sciences, Janssen Therapeutics, Merck and Co. and ViiV Healthcare. Any client who is certified as eligible to receive ADAP medications but is unable to do so because they are on a waiting list can access their medications through completion of a simple form. Individuals then receive all of their medications via mail order.
 
Please contact me mailto:mpenner@NASTAD.org if you have questions.
 
Attachments (1)
 
Murray C. Penner, Deputy Executive Director
National Alliance of State & Territorial AIDS Directors (NASTAD)
444 North Capitol Street NW, Suite 339
Washington, DC 20001
Phone: (202) 434.8099 Fax: (202) 434.8092
 
------------------------------------
 
For Immediate Release
 
Bristol-Myers Squibb Supports HarborPath to Help Uninsured Individuals Living with HIV/AIDS Access Prescription Medicines
 
- HarborPath's Partners Now Include Bristol-Myers Squibb, Gilead Sciences, Merck and ViiV Healthcare -
 
Columbia, SC - October 1, 2013 HarborPath, an organization which provides a single point of access to HIV/AIDS medications through patient assistance programs, welcomes Bristol-Myers Squibb as a participating company. Bristol-Myers Squibb, which is donating HIV/AIDS medications and funding, is the latest pharmaceutical company to support HarborPath with donated medications since its formation in July 2012.
 
"The support of Bristol-Myers Squibb brings us one step closer to offering uninsured individuals living with HIV/AIDS access to their full regimen of medications through patient assistance programs," said Ken Trogdon, Jr., President of HarborPath. "Access to life-saving medications is vital to individuals living with HIV, and these programs are invaluable to individuals who cannot afford their medications. We are thankful for the support of our pharmaceutical company partners, and we encourage others to join our efforts to streamline the application and medication fulfillment process to provide medications quickly to those who need them most."
 
HarborPath is currently working with clinics in seven states and Washington, D.C. to help healthcare professionals and case managers connect individuals living with HIV/AIDS to multiple patient assistance programs using the common application form on the HarborPath website. As of May 2013, HarborPath began administering the AIDS Drug Assistance Program (ADAP) Waiting List Program. Medications donated by pharmaceutical companies are dispensed to individuals who are on ADAP Waiting Lists through the HarborPath mail-order pharmacy.
 
"For the last 20 years, Bristol-Myers Squibb has worked collaboratively with the HIV/AIDS community to help meet the diverse needs of patients living with this disease - from developing medicines to supporting disease education efforts to ongoing clinical research," said Kabir Nath, senior vice president, U.S. Virology, Bristol Myers Squibb. "We are committed to helping ensure HIV patients have access to treatments now and in the future. Our partnership with HarborPath allows us to extend the reach of our patient assistance programs and help more individuals have access to therapy."
 
About HarborPath
 
HarborPath is a 501(c) (3) organization whose mission is to provide streamlined access to HIV/AIDS medications through patient assistance programs via an online portal. For more information, visit www.harborpath.org.
 
Media Contacts:
Mike Beyer
Sam Brown Inc. PR for HarborPath
312-961-2502
beyer@sambrown.com
Ken Trogdon, Jr.
President
HarborPath
803-807-9159
ken.trogdon@harborpath.org

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org